Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering antibodies for clinical applications.

Maneesh Jain1, Neel Kamal, Surinder K Batra

  • 1Department of Biochemistry and Molecular Biology, Department of Pathology and Microbiology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA.

Trends in Biotechnology
|May 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer.

Acta biomaterialia·2026
Same author

Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Anatomical Coordinates for Adductor Canal Block: Targeting Saphenous Nerve and Nerve to Vastus Medialis.

Acta anaesthesiologica Scandinavica·2026
Same author

Historical Perspective of HER2 Testing and Treatment in Prostate Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

QR Codes in medical education: A mixed-method for evaluation of effectiveness and learner perception.

Bioinformation·2026
Same author

Utility of the US Preventive Services Task Force for Preeclampsia Risk Assessment and Aspirin Prophylaxis.

Obstetrical & gynecological survey·2026
Same journal

Smart biomaterials: From responsiveness to closed-loop sensing and feedback.

Trends in biotechnology·2026
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
See all related articles

Antibody engineering enhances therapeutic antibodies by modifying size, pharmacokinetics, and effector functions. This molecular engineering approach improves antibody clinical utility for various applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Antibodies are crucial in modern medicine.
  • Molecular engineering has significantly advanced antibody applications.
  • The modular nature of antibodies allows for extensive modifications.

Purpose of the Study:

  • To review recent advancements in antibody engineering.
  • To highlight how these engineering strategies improve clinical utility.
  • To discuss the development of antibody-based therapeutics and diagnostics.

Main Methods:

  • Review of current literature on antibody engineering techniques.
  • Analysis of modifications including size, pharmacokinetics, immunogenicity, affinity, specificity, and effector functions.
  • Exploration of antibody fusion proteins for targeted therapies and imaging.

Related Experiment Videos

Main Results:

  • Antibody engineering enables precise tuning of antibody properties.
  • Modifications enhance therapeutic efficacy and reduce adverse effects.
  • Fusion proteins create novel agents for targeted drug delivery, biological modification, and imaging.

Conclusions:

  • Antibody engineering is a key driver of success for antibody-based therapies.
  • Ongoing innovations continue to expand the clinical applications of engineered antibodies.
  • Future directions involve further optimization for enhanced patient outcomes.